(redirected from booster dose)
Also found in: Dictionary, Thesaurus, Medical, Financial, Encyclopedia, Wikipedia.
See: drug
References in periodicals archive ?
In addition, "a booster dose interval of 6 months or more may be considered by public health officials depending on the specific outbreak, vaccine strategy, and projected duration of elevated risk."
They said the World Health Organisation (WHO) had made it mandatory to provide every child with the booster dose, but the authorities in Punjab remained unconcerned over the issue.
Persistence of hSBA responses [greater than or equal to] 1:4 * and GMTs ([dagger]) against four selected serogroup B meningococcal strains ([section]) at 48 months (m) in subjects aged 11-18 years ([paragraph]) after completion of a 2-dose (0, 6 months) or 3-dose (0, 2, 6 months) series of MenB-FHbp, and hSBA responses [greater than or equal to] 1:4 and GMTs to a booster dose of MenB-FHbp at approximately 48 months after primary vaccination
Plasma from young adults receiving a booster dose of vaccine could represent a potential source of human DAT.
coli O78 strain (Figure 5), it is clear that the geometric mean of MAT in inactivated vaccine was increased from 127 at 1st week after vaccination to 201at 3rd week and decreased to160 at 1st to 3rd week after booster dose while the titer after challenge decreased to 80 at 1st week and 2ndweek.
at a later age and further investigation of a booster dose for elderly individuals at an appropriate interval after initial immunization against HZ," Dr.
The age was not lowered because of a concern about vaccine supply and the uncertainty about the possible need for a booster dose if administered at age 50.
(3) Based on their protective efficacy and improved safety and reactogenicity, the World Health Organization (WHO) recommends aP vaccines for primary vaccination, and a booster dose preferably during the second year of life.
ATLANTA--A booster dose of meningococcal conjugate vaccine should be given to adolescents at 16 years of age if they received a first dose at age 11-12 years, and a booster should be given 5 years after the first dose--up to age 21 years--to those who first received the vaccine at age 13-15 years.
Researchers said the decrease was likely due to a shortage of the vaccine that began in December 2007 and a temporary recommendation to defer the booster dose. Coverage increased in 2008 for three or more doses of pneumoccocal conjugate vaccine.
Children in the UK are offered vaccination against measles as part of the MMR vaccine, which is given to them between 12 and 15 months of age followed by a booster dose before they start school.